FeesSafety
Pluang+

Apimeds reports $2.89M Q3 revenue, first from tech services, with $2M operating income and $33.6M net income.

Company Fundamentals
18 Nov 2026, 15:44 WIB
GlobeNewsWire
View Source
Bullish
Apimeds reports $2.89M Q3 revenue, first from tech services, with $2M operating income and $33.6M net income.

Apimeds Pharmaceuticals US, Inc. reported $2.89 million in revenue for Q3 2026, marking its first full quarter of revenue from its technology services business. The company achieved $2.0 million in operating income and a net income of $33.6 million, boosted by a $25.26 million unrealized gain on digital assets. Apimeds completed its transition from biopharmaceuticals to technology infrastructure, signing new enterprise agreements in climate finance, sports media, and insurance sectors. The company is focused on delivering projects, converting contracts into recurring revenue, and addressing liquidity concerns with upcoming debt maturity and capital raising efforts.

Apimeds Pharmaceuticals US reports its Q3 2026 results, including $2.89 million revenue and $33.6 million net income. For readers following technology stocks, here is Pluang's market snapshot as of Nov 18, 2026 20:41 WIB: 97 of 150 US technology stocks rose, 49 fell. Notable movers include Dolby Laboratories at USD 55.50 (-5.64%), Veritone Inc at USD 0.38 (+5.21%, 65% buy orders), and Applied Digital Corporation at USD 14.96 (+5.20%, 78% buy orders).

More News

Dividend 15 Split Corp. declares monthly dividends for Class A and Preferred shares payable December 10, 2026.

Dividend 15 Split Corp. declares monthly dividends for Class A and Preferred shares payable December 10, 2026.

Dividend 15 Split Corp. announced monthly dividend payments of $0.10 per Class A share and $0.05833 per Preferred share, payable on December 10, 2026, to shareholders recorded by November 30, 2026. Since inception, Class A shares have distributed $29...

Company Fundamentals
Neutral
52 minutes ago
Stewards launches SBC Express, offering up to $10,000 to small businesses within two hours using AI underwriting.

Stewards launches SBC Express, offering up to $10,000 to small businesses within two hours using AI underwriting.

Stewards Inc. has launched SBC Express, a new AI-enabled digital financing product that allows qualified small businesses to apply for and receive up to $10,000 in revenue-based financing in as little as two hours. The platform integrates application...

Market News
Bullish
52 minutes ago
VolitionRx downgraded to Hold despite progress in cancer and sepsis diagnostics.

VolitionRx downgraded to Hold despite progress in cancer and sepsis diagnostics.

Freedom Broker downgraded VolitionRx to Hold while the company reported significant advancements in its Nu.Q diagnostic platform, including over 95% accuracy in early-stage cancer detection and peer-reviewed validation in sepsis. VolitionRx expanded ...

Analyst Insights
Neutral
1 hour ago
Lowe's beats Q3 earnings estimates and raises full-year sales outlook.

Lowe's beats Q3 earnings estimates and raises full-year sales outlook.

Lowe's reported adjusted earnings per share of $3.10, surpassing estimates of $2.88, and revenue of $22.80 billion, beating the $22.40 billion forecast. Comparable sales rose 1.8%, driven by strong online and professional services sales. The company ...

Company Fundamentals
Bullish
1 hour ago
Major Memphis health system expands Daxor's blood volume testing to new outpatient site with 24-hour results.

Major Memphis health system expands Daxor's blood volume testing to new outpatient site with 24-hour results.

Daxor Corporation announced that a major Memphis health system has expanded its Blood Volume Analysis (BVA) program to an additional hospital outpatient site using Daxor’s ezBVA Lab service. This expansion allows the outpatient clinic to receive bloo...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App